Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?
作者信息
Hung Chi F, Raghu Ganesh
机构信息
Department of Medicine, Center for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.
Department of Laboratory Medicine and Pathology, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington, USA.
出版信息
Respirology. 2024 Sep;29(9):747-750. doi: 10.1111/resp.14788. Epub 2024 Jul 3.
Abstract
摘要
相似文献
1
Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?
Respirology. 2024 Sep;29(9):747-750. doi: 10.1111/resp.14788. Epub 2024 Jul 3.
2
Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.
Respir Med. 2021 Jul;183:106400. doi: 10.1016/j.rmed.2021.106400. Epub 2021 Apr 26.
3
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review.
Thorax. 2025 Feb 17;80(3):140-149. doi: 10.1136/thorax-2024-222636.
4
Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
Sci Rep. 2021 Mar 11;11(1):5762. doi: 10.1038/s41598-021-85539-1.
5
Monthly pulse methylprednisolone infusions in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases: a single-center retrospective analyses.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251342661. doi: 10.1177/17534666251342661. Epub 2025 May 30.
6
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease.
Respirology. 2024 Sep;29(9):795-802. doi: 10.1111/resp.14763. Epub 2024 Jun 2.
7
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
Lung. 2020 Aug;198(4):597-608. doi: 10.1007/s00408-020-00370-1. Epub 2020 Jun 26.
8
Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Respir Med. 2021 Sep;186:106534. doi: 10.1016/j.rmed.2021.106534. Epub 2021 Jul 7.
9
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758.
10
The Impact of Corticosteroids on Mortality in Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Meta-Analysis.
Adv Respir Med. 2025 Mar 28;93(2):6. doi: 10.3390/arm93020006.
引用本文的文献
1
Potential Utility of Combined Presepsin and LDH Tracking for Predicting Therapeutic Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Interstitial Lung Diseases: A Pilot Study.
J Clin Med. 2025 Apr 29;14(9):3068. doi: 10.3390/jcm14093068.
本文引用的文献
1
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease.
Respirology. 2024 Sep;29(9):795-802. doi: 10.1111/resp.14763. Epub 2024 Jun 2.
2
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
BMC Pulm Med. 2024 Mar 20;24(1):143. doi: 10.1186/s12890-024-02957-3.
3
Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Respir Res. 2022 Oct 26;23(1):291. doi: 10.1186/s12931-022-02195-3.
4
A sudden deterioration in idiopathic pulmonary fibrosis.
Lancet Respir Med. 2021 Nov;9(11):1342. doi: 10.1016/S2213-2600(21)00416-1.
5
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7.
6
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.
Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC.
7
Acute exacerbations of fibrotic interstitial lung diseases.
Respirology. 2020 May;25(5):525-534. doi: 10.1111/resp.13682. Epub 2019 Aug 19.
8
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.
Lancet Respir Med. 2018 Sep;6(9):707-714. doi: 10.1016/S2213-2600(18)30301-1. Epub 2018 Aug 9.
9
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years.
Eur Respir J. 2017 Oct 26;50(4). doi: 10.1183/13993003.01209-2017. Print 2017 Oct.
10
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI.
Zotero 插件